Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Hologic Inc.

May 2009
Bedford, Mass.-based Hologic Inc. has received FDA approval for two of its tests for the human papilloma virus. The company’s HPV HR (high risk) and HPV 16/18 were designed to detect the 14 high-risk types of the virus, known to cause cervical cancer, and to detect types 16 and 18, which are associated with about 70 percent of cervical cancers, respectively.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!